CCL2 and gestational diabetes: When GDM or maternal obesity is present, there is an increase in placental proinflammatory cytokine levels; this exposes the fetus to TNF-α, monocyte chemotactic protein-1 (MCP-1), IL-1, and IL-6, among others.